口服蒙特卢卡斯特对控制儿童喘发作的影响:一项随机双盲,安慰剂控制的随机研究
Mohsen Jafari1, Masoomeh Sobhani2, Kambiz Eftekhari3
1Division of Infectious Diseases, Department of Pediatrics, Bahrami Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran. mohsenjafari48@gmail.com.
Iranian journal of allergy, asthma, and immunology
|December 12, 2023
概括
这项研究发现,口服蒙特卢卡斯特在与标准治疗一起使用时,对患有喘发作的儿童没有额外的益处. 在急诊期间,该药物并没有显著改善儿科患者的喘严重程度或氧气水平.
科学领域:
- 儿科肺病学 儿科肺病学
- 临床药理学 临床药理学
- 紧急医疗 紧急医疗
背景情况:
- 口服蒙特卢卡斯特是一种常见的持续性喘的维持疗法.
- 它在治疗急性喘发作,特别是儿童的有效性仍在争论中.
- 目前的指导方针并不普遍建议蒙特卢卡斯特用于急性喘恶化.
研究的目的:
- 评估口服蒙特卢卡斯特作为儿童急性喘发作辅助治疗的临床有效性.
- 为了比较接受蒙特卢卡斯特与安慰剂的儿童的喘发作严重程度和氧气和.
- 评估对住院时间和重症监护室入院的影响.
主要方法:
- 一个双盲,安慰剂控制的临床试验,涉及80名儿童 (年龄在1-14岁) 接受了喘发作.
- 患者接受了标准的喘发作治疗,再加上口服蒙特卢卡斯特或安慰剂一周.
- 主要结局包括喘发作严重程度得分和外周氧和度 (SpO2),在入院后的多个时间点测量.
主要成果:
- 在最初的48小时内,在蒙特卢卡斯特和安慰剂组之间没有观察到喘发作严重性得分或SpO2的显著差异.
- 住院时间和重症监护室入院率在两组之间没有显著差异.
- 没有患者在出院后需要重新住院,无论治疗组如何.
结论:
- 口服蒙特卢卡斯特,当添加到标准治疗儿童急性喘发作时,没有提供额外的临床益处.
- 该研究表明,蒙特卢卡斯特在改善儿科喘恶化期间的关键结果方面并不有效.
- 可能需要进一步的研究来澄清蒙特卢卡斯特的作用,如果有的话,在特定的儿科喘情景.
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
317
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
317
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
266
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
266
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
271
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
271
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K